Zoe Harrison
VP, Accounting and Corporate Development
Replay available
DarioHealth Corp. (NASDAQ: DRIO) Q3 2025 earnings conference call, held 2025-11-13. Replay captured from the company's public earnings webcast.

VP, Accounting and Corporate Development
Chief Executive Officer
President and Chief Commercial Officer
Chief Financial Officer
Analyst, Leachfield Health Research
Participant
Executive
Good morning, ladies and gentlemen, and welcome to the Dario Health third quarter 2025 results conference call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question and answer session. If you require immediate assistance during this call, please press star zero at any time for the operator. This call is being recorded on Thursday, November 13th of 2025. I would now like to turn the conference over to Zoe Harrison, VP Accounting and Corporate Development at Dario Health. Zoe, please go ahead. Thank you, Operator, and good morning, everyone. Thank you for joining us today for a discussion of Dario Health's third quarter 2025 financial results. Leading the call today will be Erez Rafael, Chief Executive Officer of Dario Health. He'll be joined by our President and Chief Commercial Officer, Stephen Nelson. and Hen Franco, our Chief Financial Officer. An audio recording and webcast replay for today's call will also be available online as detailed in the press release invite for this call. For the benefit of those who may be listening to the replay or archived webcast, this call is being held on Thursday, November 13, 2025. This morning, we issued a press release announcing our financial results for the third quarter of 2025. The copy of the release can be found on the investor relations page of Dario Health website. I'd like to remind you that on this call, management will make forward-looking statements within the meaning of the federal securities laws. For example, the company is using forward-looking statements when it is discussing amount of its targeted new business, its 2026 pipeline, and expected strong revenue acceleration in 2026, that it expects to reach cash flow breakeven by late 2026 to early 2027, that it ...